CSBR:NASDAQ
Champions Oncology Inc
4,70 USD
0,00%
(0,00) 1D
13-ноя., 15:57:39 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Mkt. cap
65,49 млн
Avg. vol.
8,15 миң
Volume
219,00
52-wk high
8,31 USD
52-wk low
4,52 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Mkt. cap
65,49 млн
Avg. vol.
8,15 миң
Volume
219,00
52-wk high
8,31 USD
52-wk low
4,52 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
marketscreener.com
·
21 мүнөт мурун
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
21 мүнөт мурун
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Benzinga
·
1 саат мурун
Forget Nvidia — S&P 500's 8,900 Target Puts These ETFs in Play - State Street SPDR S&P 500 ETF Trust (ARC
BigGo Finance
·
3 саат мурун
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью Джерси, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitechampionsoncology.com